ChiCTR2500099194 版本V1.0 版本创建时间2025/03/19 16:28:58 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2500099194 

最近更新日期:

Date of Last Refreshed on:

2025-03-19 16:28:40 

注册时间:

Date of Registration:

2025-03-19 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

高风险作业人员勇敢心理素质虚拟现实刺激场景及训练场景的有效性验证

Public title:

The effectiveness of virtual reality training in enhancing the psychological qualities of personnel engaged in high-risk operations

注册题目简写:

English Acronym:

研究课题的正式科学名称:

高风险作业人员勇敢心理素质虚拟现实刺激场景及训练场景的有效性验证

Scientific title:

The effectiveness of virtual reality stimulation scenarios and training scenarios for enhancing the courageous psychological qualities of personnel in high-risk occupations

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

王慧中 

研究负责人:

王佳 

Applicant:

Huizhong Wang 

Study leader:

Jia Wang 

申请注册联系人电话:

Applicant telephone:

+86 185 0692 6086

研究负责人电话:

Study leader's
telephone:

+86 158 2601 6915

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1030715381@qq.com

研究负责人电子邮件:

Study leader's E-mail:

wangjia@tmmu.edu.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

陕西省西安市新城区长乐西路169号

研究负责人通讯地址:

重庆市沙坪坝区高滩岩正街30号

Applicant address:

169 Changle West Road, Xincheng District, Xi 'an City, Shaanxi Province

Study leader's address:

No. 30, Gaotan Yanzheng Street, Shapingba District, Chongqing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

中国人民解放军陆军军医大学

Applicant's institution:

Army Medical University, PLA

研究负责人所在单位:

中国人民解放军陆军军医大学

Affiliation of the Leader:

Army Medical University, PLA

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2021-第14-02

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

中国人民解放军陆军军医大学医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Army Medical University, PLA

伦理委员会批准日期:

Date of approved by ethic committee:

2021-07-14 00:00:00

伦理委员会联系人:

于晓东

Contact Name of the ethic committee:

Xiaodong Yu

伦理委员会联系地址:

重庆市沙坪坝区高滩岩正街30号

Contact Address of the ethic committee:

No. 30, Gaotan Yanzheng Street, Shapingba District, Chongqing

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 166 2346 0852

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

中国人民解放军陆军军医大学

Primary sponsor:

Army Medical University, PLA

研究实施负责(组长)单位地址:

重庆市沙坪坝区高滩岩正街30号

Primary sponsor's address:

No. 30, Gaotan Yanzheng Street, Shapingba District, Chongqing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

重庆市

市(区县):

Country:

China

Province:

Chongqing

City:

单位(医院):

中国人民解放军陆军军医大学

具体地址:

重庆市沙坪坝区高滩岩正街30号

Institution
hospital:

Army Medical University, PLA

Address:

No. 30, Gaotan Yanzheng Street, Shapingba District, Chongqing

经费或物资来源:

国家社会科学基金立项课题

Source(s) of funding:

National Social Science Foundation of China

研究疾病:

心理素质提升  

Target disease:

Psychological quality improvement

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

利用虚拟现实技术模拟高应激环境,研发高危作业人员心理素质训练的虚拟现实刺激库,为提升应对危险作业环境时的勇敢素质训练提供信息化技术支撑。  

Objectives of Study:

Utilizing virtual reality technology to simulate high-stress environments, we develop a virtual reality stimulus library for psychological training of high-risk operators, providing information technology support for enhancing bravery training in response to hazardous operational environments.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

(1)≥18岁,男女不限 (2)右利手 (3)无精神心理疾病既往史 (4)视力或矫正视力在1.0以上 (5)无视听障碍 (6)愿意参加本研究并签署知情同意书

Inclusion criteria

1. >=18 years old, male or female 2. right-handed hands 3. No history of mental illness 4. Vision or corrected vision is above 1.0 5. Disregard for hearing impairment 6. Willing to participate in this study and sign the informed consent form

排除标准:

(1)入选研究前3月参与了其他试验研究 (2)患有心身疾病,无法配合试验者 (3)有明显3D眩晕症,无法配合试验者

Exclusion criteria:

1. Participated in other experimental studies within the first three months prior to being selected for the study 2. Those who suffer from psychosomatic diseases and cannot cooperate with the experiment 3. Subjects with obvious 3D vertigo and unable to cooperate with the experiment

研究实施时间:

Study execute time:

From 2021-08-01 00:00:00 To 2022-07-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-10-19 00:00:00 To 2022-03-25 00:00:00

干预措施:

Interventions:

组别:

训练组

样本量:

40

Group:

Training group

Sample size:

干预措施:

针对性虚拟现实训练

干预措施代码:

Intervention:

Targeted virtual reality training

Intervention code:

组别:

对照组

样本量:

40

Group:

Control group

Sample size:

干预措施:

非针对性虚拟现实训练

干预措施代码:

Intervention:

Non-targeted virtual reality training

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

重庆市 

市(区县):

 

Country:

China

Province:

Chongqing

City:

单位(医院):

中国人民解放军陆军军医大学 

单位级别:

大学 

Institution
hospital:

Army Medical University, PLA

Level of the institution:

University

测量指标:

Outcomes:

指标中文名:

心理素质量表

指标类型:

主要指标

Outcome:

the Mental quality scale

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

眼动

指标类型:

次要指标

Outcome:

Eye Movement

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

心率

指标类型:

次要指标

Outcome:

Heart Rate

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

心率变异性

指标类型:

次要指标

Outcome:

Heart Rate Variability (HRV)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

皮肤电导

指标类型:

次要指标

Outcome:

Skin conductance

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肌电

指标类型:

次要指标

Outcome:

Electromyography (EMG)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

作业绩效

指标类型:

附加指标

Outcome:

Job Performance

Type:

Additional indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

本试验的随机序列由团队的实验员生成,使用SPSS创建了一个随机分配列表,确保每个参与者被分配到不同干预组的概率相等。生成随机序列的过程严格遵守保密原则,避免任何形式的偏差或泄漏。

Randomization Procedure (please state who generates the random number sequence and by what method):

The allocation sequence for this trial was generated by a laboratory technician. She used SPSS to create a randomized allocation list, ensuring that each participant had an equal probability of being assigned to different intervention groups. The process of generating the allocation sequence adhered strictly to confidentiality principles to avoid any form of bias or leakage.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

可根据合理要求提供原始数据,国家生物信息中心 (https://ngdc.cncb.ac.cn/gsub/)

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

We can provide the study data upon reasonable request. China National center for Bioinformation (https://ngdc.cncb.ac.cn/gsub/)

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2025-03-19 16:28:40